Ethan H. Beckley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ethan H. Beckley has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Deborah A. Finn
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, USA
4 shared publications - Matthew M. Ford
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239
3 shared publications Katherine R. Gililland
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA
2 shared publicationsPaula H. Bednarek
2 shared publicationsAlison B. Edelman
1 shared publicationAmy S. Beadles-Bohling
Portland Alcohol Research Center, Department of Veterans Affairs Medical Research and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA
1 shared publication
Latest Publications
- 9 April 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (7) , e209275
Teaching Video NeuroImage: Rabbit Syndrome
- 9 April 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 102 (7) , e209275
Teaching Video NeuroImage: Rabbit Syndrome
- 11 January 2019
- Published by The Endocrine Society in Endocrinology
- Vol. 160 (2) , 460
Letter to the Editor: “Hysterectomy Uniquely Impacts Spatial Memory in a Rat Model: A Role for the Nonpregnant Uterus in Cognitive Processes”
Ethan H Beckley; Letter to the Editor: Hysterectomy uniquely impacts spatial memory in a rat model: A role for the nonpregnant uterus in cognitive processes.,
- 11 January 2019
- Published by The Endocrine Society in Endocrinology
- Vol. 160 (2) , 460
Letter to the Editor: “Hysterectomy Uniquely Impacts Spatial Memory in a Rat Model: A Role for the Nonpregnant Uterus in Cognitive Processes”
Ethan H Beckley; Letter to the Editor: Hysterectomy uniquely impacts spatial memory in a rat model: A role for the nonpregnant uterus in cognitive processes.,
- 11 March 2016
- Published by Wiley in Journal of Midwifery & Women's Health
- Vol. 61 (3) , 325-330
Aspiration Abortion With Immediate Intrauterine Device Insertion: Comparing Outcomes of Advanced Practice Clinicians and Physicians
Introduction: Immediate postabortion intrauterine device (IUD) insertion is a safe, effective strategy to prevent subsequent unplanned pregnancy. Oregon is one of 5 US states where advanced practice clinicians perform aspiration abortions. This study compares outcomes of first‐trimester aspiration abortion with immediate IUD insertion between advanced practice clinicians and physicians.Methods: We conducted a historical cohort study of first‐trimester aspiration abortions with immediate IUD insertion performed at our center from 2009 to 2011. We extracted demographic and clinical data from patient charts. Immediate complications including excessive blood loss, perforation, and reaspirations were recorded at the time of procedure. We used descriptive statistics and multivariable logistic regression to test for differences in outcomes by clinician type.Results: Data were available on 669 of the 1134 combined procedures. Advanced practice clinicians performed 224 of these. There were no significant differences in immediate outcomes. The only immediate complications were reaspirations; 1.8% (4/224) in the advanced practice clinician group, and 2.0% (9/445) in the physician group (P = .83).Discussion: We found no differences in outcomes between provider type for immediate IUD insertion after first‐trimester aspiration abortion. This study helps reinforce that advanced practice clinicians can provide immediate postaspiration abortion IUD insertions with similar outcomes to those of physicians. Many countries do not allow advanced practice clinicians to perform this service, but a change in policy could help address family planning provider shortages.
- 11 March 2016
- Published by Wiley in Journal of Midwifery & Women's Health
- Vol. 61 (3) , 325-330
Aspiration Abortion With Immediate Intrauterine Device Insertion: Comparing Outcomes of Advanced Practice Clinicians and Physicians
Introduction: Immediate postabortion intrauterine device (IUD) insertion is a safe, effective strategy to prevent subsequent unplanned pregnancy. Oregon is one of 5 US states where advanced practice clinicians perform aspiration abortions. This study compares outcomes of first‐trimester aspiration abortion with immediate IUD insertion between advanced practice clinicians and physicians.Methods: We conducted a historical cohort study of first‐trimester aspiration abortions with immediate IUD insertion performed at our center from 2009 to 2011. We extracted demographic and clinical data from patient charts. Immediate complications including excessive blood loss, perforation, and reaspirations were recorded at the time of procedure. We used descriptive statistics and multivariable logistic regression to test for differences in outcomes by clinician type.Results: Data were available on 669 of the 1134 combined procedures. Advanced practice clinicians performed 224 of these. There were no significant differences in immediate outcomes. The only immediate complications were reaspirations; 1.8% (4/224) in the advanced practice clinician group, and 2.0% (9/445) in the physician group (P = .83).Discussion: We found no differences in outcomes between provider type for immediate IUD insertion after first‐trimester aspiration abortion. This study helps reinforce that advanced practice clinicians can provide immediate postaspiration abortion IUD insertions with similar outcomes to those of physicians. Many countries do not allow advanced practice clinicians to perform this service, but a change in policy could help address family planning provider shortages.
- 1 November 2012
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 120 (5) , 1060-1069
Hydrocodone–Acetaminophen for Pain Control in First-Trimester Surgical Abortion
Although hydrocodone–acetaminophen is commonly used for pain control in first-trimester abortion, the efficacy of oral opioids for decreasing pain has not been established. Our objective was to estimate the effect of hydrocodone–acetaminophen on patient pain perception during first-trimester surgical abortion. We conducted a randomized, double-blinded, placebo-controlled trial. Patients (before 11 weeks of gestation) received standard premedication (ibuprofen and lorazepam) and a paracervical block with the addition of 10 mg hydrocodone and 650 mg acetaminophen or placebo 45–90 minutes before surgical abortion. A sample size of 120 was calculated to provide 80% power to show a 15-mm difference (α=0.05) in the primary outcome of pain with uterine aspiration (100-mm visual analog scale). Secondary outcomes were pain at additional time points, satisfaction, side effects, adverse events, and need for additional pain medications. There were no significant differences in demographics or baseline pain between groups. There were no differences in pain scores between patients receiving hydrocodone–acetaminophen compared with placebo during uterine aspiration (65.7 mm compared with 63.2 mm, P=.59) or other procedural time points. There were no differences in satisfaction or need for additional pain medications. Patients who received hydrocodone–acetaminophen had more postoperative nausea than those receiving placebo (P=.03) when controlling for baseline nausea. No medication-related adverse events were noted. Hydrocodone–acetaminophen does not decrease pain during first-trimester abortion and may increase postoperative nausea. Clinicaltrials.gov, www.clinicaltrials.gov, NCT01330459. I
- 1 November 2012
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 120 (5) , 1060-1069
Hydrocodone–Acetaminophen for Pain Control in First-Trimester Surgical Abortion
Although hydrocodone–acetaminophen is commonly used for pain control in first-trimester abortion, the efficacy of oral opioids for decreasing pain has not been established. Our objective was to estimate the effect of hydrocodone–acetaminophen on patient pain perception during first-trimester surgical abortion. We conducted a randomized, double-blinded, placebo-controlled trial. Patients (before 11 weeks of gestation) received standard premedication (ibuprofen and lorazepam) and a paracervical block with the addition of 10 mg hydrocodone and 650 mg acetaminophen or placebo 45–90 minutes before surgical abortion. A sample size of 120 was calculated to provide 80% power to show a 15-mm difference (α=0.05) in the primary outcome of pain with uterine aspiration (100-mm visual analog scale). Secondary outcomes were pain at additional time points, satisfaction, side effects, adverse events, and need for additional pain medications. There were no significant differences in demographics or baseline pain between groups. There were no differences in pain scores between patients receiving hydrocodone–acetaminophen compared with placebo during uterine aspiration (65.7 mm compared with 63.2 mm, P=.59) or other procedural time points. There were no differences in satisfaction or need for additional pain medications. Patients who received hydrocodone–acetaminophen had more postoperative nausea than those receiving placebo (P=.03) when controlling for baseline nausea. No medication-related adverse events were noted. Hydrocodone–acetaminophen does not decrease pain during first-trimester abortion and may increase postoperative nausea. Clinicaltrials.gov, www.clinicaltrials.gov, NCT01330459. I
- 1 July 2011
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 36 (6) , 824-833
Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability
- 1 July 2011
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 36 (6) , 824-833
Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability
- 1 January 2010
- Published by Elsevier in Hormones and Behavior
- Vol. 57 (1) , 12-22
Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors
- 1 January 2010
- Published by Elsevier in Hormones and Behavior
- Vol. 57 (1) , 12-22
Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors
- 1 November 2008
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 29 (11) , 537-543
Multivariate analyses reveal common and drug-specific genetic influences on responses to four drugs of abuse
- 1 November 2008
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 29 (11) , 537-543
Multivariate analyses reveal common and drug-specific genetic influences on responses to four drugs of abuse
- 1 September 2008
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 97 (1-2) , 73-85
Ethanol intake patterns in female mice: Influence of allopregnanolone and the inhibition of its synthesis
- 1 September 2008
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 97 (1-2) , 73-85
Ethanol intake patterns in female mice: Influence of allopregnanolone and the inhibition of its synthesis
- 22 October 2007
- Published by Elsevier in Neuropharmacology
- Vol. 54 (2) , 365-374
Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice
- 22 October 2007
- Published by Elsevier in Neuropharmacology
- Vol. 54 (2) , 365-374
Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice
- 1 October 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 87 (4) , 412-419
Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility
- 1 October 2007
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 87 (4) , 412-419
Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility